PHARMACEUTICAL COMPOSITIONS OF MONTELUKAST AND LEVOCETIRIZINE.
- 专利权人:
- GLENMARK PHARMACEUTICALS LIMITED
- 发明人:
- ULHAS DHUPPAD
- 申请号：
- MX2013003022
- 公开号：
- MX2013003022A
- 申请日:
- 2013.03.15
- 申请国别(地区):
- MX
- 年份:
- 2014
- 代理人:
- 摘要：
- The patent application refers to pharmaceutical compositions of fixed doses for oral administration, which comprises montelukast or salts thereof and levocetirizine or the salts thereof.La solicitud de patente se refiere a las composiciones farmacéuticas de dosis fijas para administración oral que comprende montelukast o sus sales y levocetirizina o sus sales.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Stable Pharmaceutical Formulation for oral administration comprising levocetirizine or one of its Salts are acceptable from the standpoint of Pharmacist, and montelukast or one of its Salts are acceptable from the standpoint of pharmacist
- A STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, INCLUDING LEVOCETIRISINE OR ITS PHARMACEUTALLY ACCEPTABLE SALT, AND MONTELUKAST OR ITS PHARMACEUTICAL ACCEPTANCE
- COMPOSITIONS COMPRENANT UN AGENT D'ADMINISTRATION ET LEUR PRÉPARATION
- Method to treat vitamin B12 deficiency
- NOUVELLE FRACTION CONJUGUÉE D'ADMINISTRATION DE MÉDICAMENT POUR L'ADMINISTRATION PAR VOIE ORALE D'UN MÉDICAMENT NE CONVENANT PAS À L'ADMINISTRATION PAR VOIE ORALE ET SON PROCÉDÉ DE PRÉPARATION
